PGC-1α

Yu-Wen Cheng1,2, Jia-Hau Lee3, Chih-Hui Chang4

  • 1Department of Neurosurgery, Kaohsiung Veterans General Hospital, Kaohsiung 807, Taiwan.

Biomedicines
|May 25, 2024
PubMed
概括

过氧体增殖器激活受体γ (PPARγ) 协活性剂-1α (PGC-1α) 的高表达与晚期质瘤阶段和低生存率相关. 降低PGC-1α的调节抑制了瘤的进展,这表明它是脑瘤的治疗点.